Results 1 to 10 of about 49,158 (278)

Pneumocystis Pneumonia

open access: yesJournal of the Formosan Medical Association, 2008
Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi.
Jang-Jih Lu, Chao-Hung Lee
doaj   +5 more sources

Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences

open access: yesТуберкулез и болезни лёгких, 2022
In the regions with the high prevalence of HIV infection, it is necessary to perform differential diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.The main complaints in COVID-19 and pneumocystis pneumonia are similar and include ...
E. A. Borodulina   +2 more
doaj   +1 more source

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients

open access: yesAvicenna Journal of Medicine, 2023
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim   +9 more
doaj   +1 more source

Pneumocystis pneumonia

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2019
Atousa HAKAMIFARD, Somayeh HAJIAHMADI
doaj   +2 more sources

Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients

open access: yesInfectious Diseases of Poverty, 2020
Background Accurately differentiating pneumocystis from cytomegalovirus pneumonia is crucial for correct therapy selection in AIDS patients. Hence, the goal of this study was to compare the computerized tomography (CT) features of pneumocystis pneumonia ...
Chun-Jing Du   +11 more
doaj   +1 more source

Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina

open access: yesPathogens, 2021
Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar ...
Theodore J. Kottom   +3 more
doaj   +1 more source

Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy

open access: yesFrontiers in Pediatrics, 2023
Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells.
Lili Liu   +8 more
doaj   +1 more source

Successful treatment of severe pneumonia in a diffuse large B-cell lymphoma patient after R-CHOP chemotherapy: A case report

open access: yesSAGE Open Medical Case Reports, 2023
R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu   +4 more
doaj   +1 more source

Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model

open access: yesJournal of Fungi, 2022
Pneumocystis pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it
Adélaïde Chesnay   +4 more
doaj   +1 more source

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance [PDF]

open access: yes, 2004
Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are mainstays of PCP treatment and prophylaxis.
Atzori, C   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy